Curist Allergy Relief Tablet, Coated
NDC Package 72559-003-48

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Curist Allergy Relief (cetirizine hydrochloride) tablets is usestemporarily relieves these symptoms due to hay fever or other upper respiratory allergies:runny nosesneezingitchy, watery eyesitching of the nose or throat. This formulation utilizes a tablet, coated delivery system. Marketed by Little Pharma, Inc., this product is identified by NDC 72559-003 and is authorized under FDA application ANDA209274.

Identification & Billing

NDC Package Code
72559-003-48
Package Description
365 TABLET, COATED in 1 BOTTLE, PLASTIC
Product Code
72559-003
11-Digit Billing Format
72559000348
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Curist Allergy Relief
Non-Proprietary Name
Cetirizine Hydrochloride
Substance Name
Cetirizine Hydrochloride
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CETIRIZINE HYDROCHLORIDE 10 mg/1
Pharmacologic Class
Usage Information
Usestemporarily relieves these symptoms due to hay fever or other upper respiratory allergies:runny nosesneezingitchy, watery eyesitching of the nose or throat

Regulatory & Marketing

Labeler Name
Little Pharma, Inc.
Product Type
Human Otc Drug
FDA Application #
ANDA209274
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-26-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72559-003-48 identifies a specific commercial package of 365 tablet, coated in 1 bottle, plastic of Curist Allergy Relief, a human over the counter drug labeled by Little Pharma, Inc.. This tablet, coated is formulated for oral use and contains cetirizine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Little Pharma, Inc. on June 26, 2019. The current certification is valid through December 31, 2026.

How is this Little Pharma, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72559000348. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72559-003-48
11-Digit CMS (5-4-2)
72559-0003-48

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.